https://biolanhealth.com/wp-content/uploads/2021/10/OsasunBerri_018-1280x640.jpg
October 8, 2021by BIOLAN HEALTH

OSASUNBERRI, an inter-regional collaborative initiative for innovation and investment in the Km 0 health industry and in the health care system, was presented in Bilbao on 4 October. Its aim is to join forces, create synergies and strengthen this sector in order to achieve efficient, comprehensive and sustainable management of current needs, as well as...

https://biolanhealth.com/wp-content/uploads/2021/06/OSAXYL-DEF-44.png
June 9, 2021by BIOLAN HEALTH

The OSAXYL measurement system developed by BIOLAN HEALTH is an accurate, simple and fast portable tool to diagnose hypolactasia.  The OSAXYL measurement system developed by BIOLAN HEALTH is an accurate, simple, fast and portable tool to quantify intestinal lactase activity levels, the cause of lactose intolerance, in urine. OSAXYL will improve the health and quality...

https://biolanhealth.com/wp-content/uploads/2020/12/65A0037-HDR-Editar-1280x640.jpg
April 30, 2021by BIOLAN HEALTH

The recent expansion of SARS-COV-2 vaccines is generating an important debate about the immunity they generate against the virus, and knowing whether vaccines are effective is obviously of great concern to the population. The way to corroborate whether these vaccines have the desired effect by provoking the expected immune response is to check whether antibodies...

https://biolanhealth.com/wp-content/uploads/2021/04/800x450.jpg
April 21, 2021by BIOLAN HEALTH

This collaborative action is part of a broader agreement reached between CIC bioGUNE and BIOLAN in areas aimed at disease diagnosis and other health applications. CIC bioGUNE -a member of the Basque Research & Technology Alliance, BRTA- and BIOLAN have signed a collaboration agreement to exchange the knowledge necessary for the development, manufacture and commercialisation...

https://biolanhealth.com/wp-content/uploads/2021/03/65A0666-1280x640.jpg
March 13, 2021by BIOLAN HEALTH

The Basque SME located in Zamudio has invested heavily to equip itself with the equipment that will allow it to scale up the newly developed product.  Since January, BIOLAN has had a new product developed and validated with excellent results in terms of sensitivity (96%) and specificity (93%) and with all the necessary requirements for...